Format

Send to

Choose Destination
See comment in PubMed Commons below
Cell Stem Cell. 2013 Apr 4;12(4):385-6. doi: 10.1016/j.stem.2013.03.008.

To be immunogenic, or not to be: that's the iPSC question.

Author information

1
Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan. kaneko.shin@cira.kyoto-u.ac.jp

Abstract

The unexpected finding that autologous induced pluripotent stem cell (iPSC)-derived teratomas are immunogenic in syngeneic hosts sparked pessimism over their therapeutic potential; however, two recent reports (Guha et al., 2013 and Araki et al., 2013; the latter in this issue of Cell stem cell) contradict previous findings, showing no immunogenicity of in vitro differentiated syngeneic iPS-derived cells and supporting their safety.

PMID:
23561437
DOI:
10.1016/j.stem.2013.03.008
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center